The significance of apolipoprotein-B (Apo-B) in the elderly as a predictive factor of cardio-cerebrovascular complications

Archives of Gerontology and Geriatrics

Volumn 49, Issue 1, 2009, Pages 162-164

  Motta, Massimo ^a   Bennati, Ettore ^a   Cardillo, Elisabeth ^a   Ferlito, Laura ^a   Passamonte, Michela ^a   Malaguarnera, Mariano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acute myocardial infarction (AMI); Apolipoprotein B; Metabolic syndrome in elderly; Stroke in elderly

Indexed keywords

APOLIPOPROTEIN B;

ACUTE HEART INFARCTION; AGED; ARTICLE; CONTROLLED STUDY; ELDERLY CARE; ELECTROCARDIOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PREVALENCE; PRIORITY JOURNAL; STROKE;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; FEMALE; GENOTYPE; HUMANS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE;

EID: 67349222956     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.07.001     Document Type: Article

References (12)

1. IDF (The International Diabetes Federation), 2005. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Part 1. Worldwide Definition for Use in Clinical Practice. Available at http://idf.org.
2. ILSA (The Italian Longitudinal Study on Aging) Working Group, 1997. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int. J. Epidemiol. 26, 995-1002.
3. Jiang R., Schulze M.B., Li T., Rifai N., Stampferm M.J., Rimm E.B., and Has B. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with Type 2 diabetes. Diabetes Care 27 (2004) 1991-1997
4. Maggi, S., Zucchetto, M., Grigoletto, F., Baldereschi, M., Candelise, L., Scarpini, E., Scarlato, G., Amaducci, L., for the ILSA Group, 1994. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging Clin. Exp. Res. 6, 464-473.
5. Rahmani M., Raiszadeh F., Allahverdian S., Kiaii S., Navab M., and Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Atherosclerosis 162 (2002) 381-389
6. Sattar N., Williams K., Sniderman A.D., D'Agostino Jr. R., and Haffner S.M. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110 (2004) 2687-2693
7. Sniderman A.D., Holme I., Aastveit A., Furberg C., Walldius G., and Jungner I. Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease. Am. J. Cardiol. 100 (2007) 217-221
8. Sung K.C., and Hwang S.T. Association between insulin resistance and apolipoprotein B in normoglycemic Koreans. Atherosclerosis 180 (2005) 161-169
9. Talmud P.J., Hawe E., Miller G.J., and Humphries S.E. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1918-1923
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167.
11. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
12. World Health Organization, 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. WHO, Geneva, pp. 31-34.